Phenylbutyrate exerts adverse effects on liver regeneration and amino acid concentrations in partially hepatectomized rats
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216208%3A11150%2F16%3A10324924" target="_blank" >RIV/00216208:11150/16:10324924 - isvavai.cz</a>
Result on the web
<a href="http://onlinelibrary.wiley.com.ezproxy.is.cuni.cz/doi/10.1111/iep.12190/epdf" target="_blank" >http://onlinelibrary.wiley.com.ezproxy.is.cuni.cz/doi/10.1111/iep.12190/epdf</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1111/iep.12190" target="_blank" >10.1111/iep.12190</a>
Alternative languages
Result language
angličtina
Original language name
Phenylbutyrate exerts adverse effects on liver regeneration and amino acid concentrations in partially hepatectomized rats
Original language description
Phenylbutyrate is recommended in urea cycle disorders and liver injury to enhance nitrogen disposal by the urine. We report the effects of phenylbutyrate on liver regeneration and amino acid levels in plasma of partially hepatectomized (PH) rats. Phenylbutyrate or saline was administered at 12-h intervals to PH or laparotomized rats. Phenylbutyrate delayed the onset of liver regeneration compared to saline-treated controls, as indicated by lower hepatic DNA specific activities 18 and 24 hours post-PH, decreased hepatic fractional protein synthesis rates 24 hours post-PH, and lowered the increases in liver weights and hepatic protein and DNA contents 48 hours after PH. Hepatic DNA fragmentation (a hallmark of apoptosis) was higher in phenylbutyrate-treated animals than in controls. Phenylbutyrate decreased the glutamine and BCAA concentrations and the ratio of the BCAA to aromatic amino acids (phenylalanine and tyrosine) in the blood plasma in both hepatectomized and laparotomized animals. In conclusion, the delayed onset of liver regeneration and the decrease in BCAA to aromatic amino acid ratio in blood suggest that phenylbutyrate administration may be disastrous in subjects with acute hepatic injury and BCAA supplementation is needed when phenylbutyrate is used therapeutically.
Czech name
—
Czech description
—
Classification
Type
J<sub>x</sub> - Unclassified - Peer-reviewed scientific article (Jimp, Jsc and Jost)
CEP classification
ED - Physiology
OECD FORD branch
—
Result continuities
Project
—
Continuities
I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace
Others
Publication year
2016
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data specific for result type
Name of the periodical
International Journal of Experimental Pathology
ISSN
0959-9673
e-ISSN
—
Volume of the periodical
97
Issue of the periodical within the volume
3
Country of publishing house
GB - UNITED KINGDOM
Number of pages
7
Pages from-to
278-284
UT code for WoS article
000380913100007
EID of the result in the Scopus database
2-s2.0-84979584096